Bright Minds Biosciences, Inc. (DRUG.CX)
73.26
+2.37
(+3.34%)
CAD |
CNSX |
Oct 23, 16:00
Bright Minds Biosciences Market Cap : 722.64M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 722.64M |
| October 22, 2026 | 699.27M |
| October 21, 2026 | 764.96M |
| October 20, 2026 | 781.73M |
| October 19, 2026 | 735.37M |
| October 16, 2026 | 720.38M |
| October 15, 2026 | 755.00M |
| October 14, 2026 | 700.35M |
| October 13, 2026 | 736.55M |
| October 09, 2026 | 760.52M |
| October 08, 2026 | 725.21M |
| October 07, 2026 | 725.41M |
| October 06, 2026 | 682.60M |
| October 05, 2026 | 715.44M |
| October 02, 2026 | 696.31M |
| October 01, 2026 | 699.76M |
| September 30, 2026 | 693.74M |
| September 29, 2026 | 703.01M |
| September 28, 2026 | 723.93M |
| September 25, 2026 | 729.15M |
| September 24, 2026 | 772.06M |
| September 23, 2026 | 804.32M |
| September 22, 2026 | 854.92M |
| September 21, 2026 | 832.04M |
| September 18, 2026 | 823.75M |
| Date | Value |
|---|---|
| September 17, 2026 | 843.38M |
| September 16, 2026 | 812.01M |
| September 15, 2026 | 825.92M |
| September 14, 2026 | 878.50M |
| September 11, 2026 | 871.99M |
| September 10, 2026 | 875.04M |
| September 09, 2026 | 887.87M |
| September 08, 2026 | 904.64M |
| September 04, 2026 | 908.38M |
| September 03, 2026 | 929.99M |
| September 02, 2026 | 977.04M |
| September 01, 2026 | 963.72M |
| August 31, 2026 | 971.61M |
| August 28, 2026 | 1.002B |
| August 27, 2026 | 1.015B |
| August 26, 2026 | 1.056B |
| August 25, 2026 | 1.083B |
| August 24, 2026 | 1.064B |
| August 21, 2026 | 1.067B |
| August 20, 2026 | 1.079B |
| August 19, 2026 | 1.124B |
| August 18, 2026 | 1.131B |
| August 17, 2026 | 1.067B |
| August 14, 2026 | 1.059B |
| August 13, 2026 | 1.082B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Fennec Pharmaceuticals, Inc. | 517.10M |
| Microbix Biosystems, Inc. | 43.83M |
| Helix BioPharma Corp. | 62.63M |
| Sernova Biotherapeutics, Inc. | 41.54M |
| Hemostemix, Inc. | 11.27M |
Market Cap Related Metrics
| PEG Ratio | -0.2162 |
| Price to Book Value | 2.348 |
| Price | 73.26 |
| Earnings Yield | -3.93% |
| PEGY Ratio | -0.2162 |